Seal and logotype of Brandeis University The Heller School logo

Forum Workgroups allow members and outside experts to drill down into important policy problems at a level of detail that is not possible in our regular Policy Conferences. We have established these groups to increase the number and quality of opportunities for members to participate in the Forum, and to expand the Forum's capacity to produce high quality deliverable products.

The Forum has three Workgroups that focus on Health Care Effectiveness; Evidence-based Medicine; and Innovation in Health Care. These workgroups meet three or four times annually, and are made up of approximately 15 members including Forum sponsors and policy experts.

Effectiveness Workgroup

Started in spring 2007, the effectiveness work group develops and analyzes program and policy strategies for improving the quality and effectiveness of the U.S. health care system. These include programs implemented by payers and purchasers, delivery systems, and manufacturers.

For example, one area of focus includes strategies for improving patient compliance with appropriate therapeutic regiments. Strategies might focus on pharmaceutical benefit management, care coordination, benefit design, consumer education, or provider financial incentives to improve compliance with evidence-based best practices.

Evidence Workgroup

Also started in spring 2007, the evidence work group develops strategies for improving the availability of clinical evidence to support decision making for patients, physicians, payers and manufacturers. This includes novel strategies for improving clinical data collection, clinical research funding strategies, and organization models for generating enhanced evidence.

The group also addresses questions about how clinical evidence is used in decision making (e.g., coverage decisions) and examines strategies to support more consistent decision making across organizations.

Innovation Workgroup

Started in fall 2007, the innovation work group develops strategies for promoting more effective innovation in health care - both in medical science and in health services delivery.

This group evaluates the business and economic models that underlie development of innovative new products and processes - and examines the relationship between the economic incentives facing health care organizations and the need for a more affordable and effective health care system. The group also attempts to identify opportunities for collaboration among payers, providers, and manufacturers that will accelerate development and adoption of high value.